Skip to search formSkip to main contentSkip to account menu

cenderitide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Cenderitide is a novel designer natriuretic peptide (NP) composed of C‐type natriuretic peptide (CNP) fused to the C‐terminus of… 
Review
2017
Review
2017
Prevalence of cardiovascular (CV) disease is increasing worldwide. One of the most important risk factors for CV disease is… 
Review
2017
Review
2017
Millions of patients worldwide are admitted for acute heart failure (AHF) each year and physicians caring for these patients are… 
Review
2016
Review
2016
2016
2016
AIMS Cenderitide is a novel dual natriuretic peptide (NP) receptor chimeric peptide activator, which targets the particulate… 
2016
2016
  • J. Wojta
  • European heart journal. Cardiovascular…
  • 2016
  • Corpus ID: 41556712
This editorial refers to ‘Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase… 
2015
2015
Abstract The use of drug-eluting coronary stents has led to significant reduction in in-stent restenosis (ISR), but led to… 
Review
2013
Review
2013
Hypertension and heart failure (HF) are common diseases that, despite advances in medical therapy, continue to be associated with… 
2013
2013
Cenderitide, also known as CD-NP, is a designer peptide developed by combining native mammalian c-type natriuretic peptide (CNP… 
Highly Cited
2012
Highly Cited
2012
Natriuretic peptides (NPs) are cardioprotective through the activation of guanylyl cyclase (GC) receptors A and B. CD-NP, also…